China

With biosimilar threat under control (for now), Roche savors demand for its new drugs
Endpoints
Wed, 10/16/19 - 12:24 pm
Roche
M&A
Spark Therapeutics
China
Flow of US biotech VC dollars on track to match record 2018 levels — China? Not so much
Endpoints
Thu, 10/10/19 - 12:54 pm
biotech
venture capital
China
Merck’s KEYTRUDA approved as monotherapy in China for first-line treatment of certain patients with advanced NSCLC
Pharmaceutical Business Review
Thu, 10/3/19 - 10:37 am
Merck
Keytruda
China
non-small cell lung cancer
Could the U.S.-China trade war stifle medical device innovation?
Mass Device
Wed, 10/2/19 - 12:04 pm
China
trade war
trade
devices
R&D
Sanofi, AZ, Lilly and more win business in China's expanded cut-price purchase program
Fierce Pharma
Wed, 09/25/19 - 11:30 pm
China
Sanofi
AstraZeneca
Eli Lilly
drug pricing
Couple stole trade secrets from U.S. children’s hospital to market their Chinese biotech, prosecutors say
Stat
Mon, 09/16/19 - 10:10 pm
China
trade secrets
AZ gets China nod for Tagrisso in first-line lung cancer
Pharmaforum
Wed, 09/4/19 - 11:22 am
AstraZeneca
China
Tagrisso
non-small cell lung cancer
China expands drug bulk-buy program, puts pressure on pharma firms
Yahoo/Reuters
Mon, 09/2/19 - 12:13 pm
China
bulk buying
BeiGene's first U.S. NDA tests global development strategy
BioCentury
Sat, 08/24/19 - 11:06 am
BeiGene
China
FDA
drug development
zanubrutinib
AstraZeneca's Kidney Drug Roxadustat Gets Second Nod in China
Yahoo/Zacks.com
Fri, 08/23/19 - 10:04 am
AstraZeneca
FibroGen
China
roxadustat
chronic kidney disease
Biomedical stakeholders caution against limiting U.S.-China collaboration
BioCentury
Thu, 08/22/19 - 10:27 am
China
R&D
Is Pfizer's established drugs' decline in China the ‘canary in the coalmine?’
Fierce Pharma
Mon, 08/19/19 - 11:55 am
Pfizer
Upjohn
China
China has become a CEO-level priority for multinational pharmaceutical companies: the trend and the implications
Endpoints
Thu, 08/15/19 - 10:55 am
China
pharma industry
These 7 trends matter the most for medtech in 2019
Mass Device
Mon, 08/5/19 - 10:43 pm
China
robotic surgery
devices
Stryker
Medtronic
FDA
Intuitive Surgical
AstraZeneca raises sales forecast after second-quarter cancer drug, China boost
Yahoo/Reuters
Thu, 07/25/19 - 10:33 am
AstraZeneca
earnings
China
Novartis multiple sclerosis product Gilenya approved in China
Pharmaceutical Business Review
Mon, 07/22/19 - 09:45 am
China
Novartis
multiple sclerosis
Gilenya
HitGen joins growing Shanghai IPO queue
BioCentury
Sun, 07/14/19 - 04:11 pm
HitGen
IPOs
China
Shanghai
Megadeals Enter Biotech Realm — And 3 Other Trends To Watch In 2019
Investors Business Daily
Wed, 07/10/19 - 10:27 am
biotech
M&A
China
Trade tensions are impeding the flow of Chinese money to US biotechs — but how much?
Endpoints
Tue, 07/9/19 - 06:19 pm
China
venture capital
biotech
trade
Zai builds cancer combo strategy with rights to Incyte's PD-1 mAb
BioCentury
Wed, 07/3/19 - 12:07 am
Zai Lab
China
PD-1 inhibitors
Incyte

Pages